Insulin aspart, recombinant Subcutaneous and Samarium sm 153 lexidronam Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Samarium sm 153 lexidronam Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: samarium sm 153 lexidronam
Brand name: Quadramet
Synonyms: Samarium Sm 153 Lexidronam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Samsca
- Insulin aspart, recombinant Subcutaneous-Sanctura
- Insulin aspart, recombinant Subcutaneous-Sanctura XR
- Insulin aspart, recombinant Subcutaneous-Sancuso
- Insulin aspart, recombinant Subcutaneous-Sandimmune
- Insulin aspart, recombinant Subcutaneous-Sandimmune (Cyclosporine Injection)
- Samarium sm 153 lexidronam Intravenous-Insulin degludec
- Samarium sm 153 lexidronam Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Samarium sm 153 lexidronam Intravenous-Insulin Degludec (U-100) Vials
- Samarium sm 153 lexidronam Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Samarium sm 153 lexidronam Intravenous-Insulin degludec and liraglutide
- Samarium sm 153 lexidronam Intravenous-Insulin degludec and liraglutide Subcutaneous